Recombinant Human MARCKS Protein，His

MARCKS (Myristoylated Alanine-Rich C Kinase Substrate) protein is a highly conserved protein that plays a crucial role in various cellular processes, including cell motility, signaling, and membrane dynamics. Its unique structure features a myristoylation site that allows it to associate with cell membranes and an alanine-rich domain that interacts with phospholipids, which is pivotal for its function. The protein is implicated in several physiological processes and has been linked to various diseases, such as cancer, neurodegenerative disorders, and cardiovascular diseases. Research on MARCKS has gained traction due to its potential as a biomarker and therapeutic target. Specifically, scientists are investigating the mechanisms by which MARCKS regulates actin dynamics and cell signaling pathways. The ability of MARCKS to influence cell behavior makes it an attractive candidate for understanding disease mechanisms and developing innovative therapeutic strategies. Recent studies have focused on its role in membrane trafficking, its interaction with other signaling molecules, and how its dysregulation can lead to pathologies. Furthermore, the development of recombinant MARCKS proteins allows for in-depth studies of its functionalities and interactions in vitro, providing insights that could lead to new interventions in MARCKS-related diseases. Overall, the exploration of MARCKS and its recombinant forms represents a promising avenue for enhancing our understanding of cellular communication and developing novel therapeutic approaches.